BusinessAmgen Q3 Revenue Climbs 8% as Prolia and XGEVA Sales FallBy Helena WardNov 4, 2026, 12:02 AM UTC
BusinessAmgen Adds Former Yum! Brands CEO David Gibbs to Its BoardBy Helena WardOct 26, 2026, 10:54 PM UTC
BusinessINVESTORS SAY EXECUTIVE PAY PACKAGES AT PHARMA MAY INCENTIVIZE DRUG PRICING RISKSBy Nasdaq OMXDec 13, 2017, 6:13 PM UTC
BusinessBiopharmaceutical Market Scope Rising With Escalating Health Concerns - IndustryARCBy Nasdaq OMXMar 28, 2017, 2:30 AM UTC
